Cairo, Egypt 24 February 2023: Bristol Myers Squibb (BMS), the leading global pharmaceutical company, announced the commercialization of its first-in-class therapy (or prescription medicine) indicated
Cairo, Egypt 24 February 2023: Bristol Myers Squibb (BMS), the leading global pharmaceutical company, announced the commercialization of its first-in-class therapy (or prescription medicine) indicated